Timo Minssen
Professor
JUR Center for Advanced Studies in Bioscience Innovation Law
Karen Blixens Plads 16
2300 København S
215. Recent Advances in Medical Device Regulation. Guests, Timo Minssen, Helen Yu, Janos Meszaros, Christopher Robertson, and Preeti Mehrotra.
14/08/2020
1 Media contribution
Press/Media: Press / Media
Artificiell intelligens– löftesrik teknik med etiska utmaningar
02/06/2019
1 Media contribution
Press/Media: Press / Media
As doações de voz podem ajudar investigadores a aprender mais sobre a covid-19. É a falta de dados que dificulta há anos avanços no diagnóstico de várias doenças físicas e mentais através da voz
06/12/2020
1 Media contribution
Press/Media: Press / Media
At NY Genome Center, Legal Expert Presents Ethical Dilemmas in Gene Editing
29/08/2019
1 item of Media coverage
Press/Media: Press / Media
Comments on FDA Action Plan for Oversight of Artificial Intelligence/Machine Learning-Based Medical Software
01/01/2021
1 Media contribution
Press/Media: Press / Media
Commission’s new strategy aims to rewrite pharma rules
01/12/2020
1 Media contribution
Press/Media: Press / Media
Danmark overdrog sin vaccineproduktion til saudiarabisk firma – det kan koste danskernes helbred dyrt
17/05/2020
1 Media contribution
Press/Media: Press / Media
EU beskytter vaccine-producenter mod dyre erstatningssager
12/11/2020
1 Media contribution
Press/Media: Press / Media
Eksperter: Befolkningslaboratorium med rod i andelstanken kan eliminere de blinde pletter i sundhedsforskningen
Carsten Obel, Trine Rolighed Thomsen, Frederik Mølgaard Thayssen, Lars Münter, Kasper Karmark Iversen, Timo Minssen & Kaj Grønbæk
26/05/2021
1 Media contribution
Press/Media: Press / Media
En NY Genome Center, un experto legal presenta dilemas éticos en la edición de genes
29/08/2019
1 item of Media coverage
Press/Media: Press / Media
En klodset administrativ revolution
Timo Minssen & Ryan Long
01/06/2018
1 Media contribution
Press/Media: Press / Media
European Unified Patent Court plans for life after Brexit
19/03/2020
1 Media contribution
Press/Media: Press / Media
Flere firmaers patenter er i farezonen efter omstridt EU-dom: Selskaber, der har fået patent på forskning med visse stamceller, risikerer at komme til at stå med et ugyldigt patent i hånden
22/03/2012
1 Media contribution
Press/Media: Press / Media
GMO Regulations in Europe Are “Not Fit for Purpose”
11/11/2020
1 Media contribution
Press/Media: Press / Media
GSK's selvmordssag kan sætte gang i medicinspekulanter
17/05/2017
1 Media contribution
Press/Media: Press / Media
Gennemsigtighed i menneskeforsøg kan standse udvikling af ny medicin
30/06/2016
1 Media contribution
Press/Media: Press / Media
Genpatent avvisas av EUs patentverk: Europeiska patentmyndigheten, EPO, godkänner inte amerikanska Myriad Genetics patentansökan för diagnos av bröstcancergenen BRCA1.Men segern är ännu inte vunnen
01/06/2004
1 Media contribution
Press/Media: Press / Media
German court blocks approval of European patent system
20/03/2020
1 Media contribution
Press/Media: Press / Media
In Conversation With... Sara Gerke and Timo Minssen
23/06/2020
1 Media contribution
Press/Media: Press / Media
Influencer Dies After Drinking Pesticide During Livestream As Viewers Encouraged Her Suicide
Karen Celedonia, Marcelo Corrales Compagnucci, Michael Lowery Wilson & Timo Minssen
18/10/2021
1 item of Media coverage
Press/Media: Press / Media
Interview for WHO: Regulating digital health
01/04/2020
1 Media contribution
Press/Media: Press / Media
Interview on the Role of Patents and Licensing in the Governance of Human Genome Editing
01/06/2021
1 Media contribution
Press/Media: Press / Media
Interview with Danish Radio (DR) on compulsory licensing issues
12/02/2021
1 Media contribution
Press/Media: Press / Media
Key takeaways from IAM’s 2020 Pharma and Biotech IP event
06/02/2020
1 Media contribution
Press/Media: Press / Media
LSPN Europe 2017: Broad had ‘no clue’ about CRISPR licensing in agriculture
07/12/2017
1 Media contribution
Press/Media: Press / Media
Locus licenses CRISPR tech to Janssen in potential $818m deal
09/01/2019
1 Media contribution
Press/Media: Press / Media
Los secretos comerciales, un obstáculo para la producción de una vacuna contra la Covid-19
14/08/2020
1 Media contribution
Press/Media: Press / Media
Medicinalindustri vil fortsat skjule oplysninger om forsøg
01/02/2018
1 Media contribution
Press/Media: Press / Media
Mixed views on Broad’s fate after EPO revokes CRISPR patent
18/01/2018
1 Media contribution
Press/Media: Press / Media
Novo kaster millioner efter retsopgør med Kåre Schultz og Teva
Timo Minssen & Karin Beukel
17/01/2018
1 Media contribution
Press/Media: Press / Media
Novo styrer mod overraskende sejr i patentkrig: Berlingske Business
29/06/2016
1 Media contribution
Press/Media: Press / Media
Novo vingeskudt i patentslagsmål: Berlingske Business
15/03/2016
1 Media contribution
Press/Media: Press / Media
Når man blander kunstig intelligens med biomedicin, så er juraen essential - Interview with CeBIL Director Timo Minssen
11/10/2018
1 Media contribution
Press/Media: Press / Media
On antibiotics, capital gains, China, America’s civil war, unicorns, ties - Letters to the editor
Jonathan Darrow & Timo Minssen
25/05/2019
1 Media contribution
Press/Media: Press / Media
Pharma companies need data strategies more than ever following recent CJEU decisions
04/02/2020
1 Media contribution
Press/Media: Press / Media
Podcast-interview: Unlocking the full potential of Open Innovation in the Life Sciences through a classification system, see: https://www.ebe-biopharma.eu/wp-content/uploads/2018/01/EBE_Open-Innovation-Podcast-3.mp3
Timo Minssen & Niclas Nilsson
14/12/2017
1 Media contribution
Press/Media: Press / Media
Preparing for Antimicrobial Resistance: Vision and Social Science Mission of the INAMRSS Network
11/12/2020
1 Media contribution
Press/Media: Press / Media
Professor i sundhedsret: Er vi trygge ved at vaccineproduktion er ude af vores hænder?
19/03/2020
1 Media contribution
Press/Media: Press / Media
Professor: En coronavaccine skal udvikles hurtigt, men vi kan ikke slække for meget på sikkerheden
23/03/2020
1 Media contribution
Press/Media: Press / Media
SWEDEN’s Response to COVID-19: A tale of trust, recommendations, and odorous nudges
12/05/2020
1 Media contribution
Press/Media: Press / Media
ID: 16150437
Most downloads
-
4329
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 1: – Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2187
downloads
The Evolution of the CJEU’s Case Law on Stem Cell Patents: Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation.
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2078
downloads
När anses en bioteknologisk uppfinning vara komplett och praktiskt användbar? – Del 2: Om nyare utvecklingar kring kravet på ’industrial application’ och ’utility’ för gen- och proteinrelaterade uppfinningar i USA och Europa
Research output: Contribution to journal › Journal article › Research › peer-review
Published